PD-L1 pfeRNAs as blood-based predictors of treatment response of unresectable malignant pleural mesothelioma patients administered Durvalumab with cisplatin and pemetrexed as first-line therapyAndrei Gurau, Yuping Mei, James R. Eshleman et al.|Non-coding RNA Research|2025Cited by 4
PD-L1 pfeRNAs as Blood-Based Predictors of Treatment Response of Unresectable Malignant Pleural Mesothelioma Patients Administered Durvalumab with Cisplatin and Pemetrexed as First-Line TherapyAndrei Gurau, Yuping Mei, Suguru Yamauchi et al.|SSRN Electronic Journal|2024Cited by 0